leadf
logo-loader
AQSE:INC

Incanthera Ltd

Receive alerts
Market:
AQSE
Market Cap:
-
Price
17.50 GBX
Change
-2.78%
52 weeks high
-
52 weeks low
-

In brief

A revolutionary oncology company, targeting tumours through unique technologies.

Incanthera is committed to the development of novel treatments for solid tumours (cancers), and licensing these to large pharmaceutical companies. Operating from Manchester, with research facilities in Bradford and Salford, Incanthera Ltd was established from the University of Bradford’s Institute of Cancer Therapeutics (www.cancer.brad.ac.uk).

Snapshot

The company is a spin-out from Bradford University’s Institute of Cancer Therapeutics

Insight Widest with the analysis, Proactive gives perspectives that others don't.